Digital health companies’ total corporate venture-backed funding increased 21 percent year over year, according to a new report from CB Insights. Funding in 2019 reached a record high of $4.7 billion, compared to $3.9 billion the year prior, even as the number of investment deals stayed largely stagnant.
While Alphabet’s GV, formerly known as Google Ventures, led corporate venture investments in digital health, healthcare organizations’ venture arms rounded out the rest of the top five, according to the CB Insights analysis.
Here are the five most active corporate venture capital groups in digital health in 2019:
1. GV: 10 deals
2. Optum Ventures: 7 deals
2. BlueCross BlueShield Venture Partners: 7 deals
4. Kaiser Permanente Ventures: 6 deals
5. Providence Ventures: 5 deals
More articles on innovation:
Northwell, Xealth among 10 most innovative healthcare companies
Hartford HealthCare partners with Israel Innovation Authority
Cincinnati Children’s joins development of $100M local innovation district
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
